【市場調査レポート】前立腺特異抗原（PSA）検査のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Prostate Specific Antigen (PSA) Testing Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。前立腺特異抗原（PSA）検査のグローバル市場インサイト・予測（～2028年） / Global Prostate Specific Antigen (PSA) Testing Market Insights, Forecast to 2028 / QY2207E09279資料のイメージです。

• レポートコード：QY2207E09279
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、114ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の前立腺特異抗原（PSA）検査の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に前立腺特異抗原（PSA）検査の世界市場のxxx％を占める「ラジオイムノアッセイ」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の前立腺特異抗原（PSA）検査の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの前立腺特異抗原（PSA）検査市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの前立腺特異抗原（PSA）検査市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

前立腺特異抗原（PSA）検査のグローバル主要メーカーには、Cleveland Diagnostics、Abbott、Siemens Healthineers、DiaSorin、Roche Holding AG、Beckman Coulter、Mediwatch(LABORIE)、Boditech、Bristol Myers Squibb、GE Healthcare、Endocare、GlaxoSmith Kline、Anixa Biosciences、Ortho Clinical、Fujirebio、Merckなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

前立腺特異抗原（PSA）検査市場は、種類と用途によって区分されます。世界の前立腺特異抗原（PSA）検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ラジオイムノアッセイ、酵素イムノアッセイ

【用途別セグメント】
病院、クリニック、診断センター、研究所、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 前立腺特異抗原（PSA）検査製品概要
- 種類別市場（ラジオイムノアッセイ、酵素イムノアッセイ）
- 用途別市場（病院、クリニック、診断センター、研究所、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の前立腺特異抗原（PSA）検査販売量予測2017-2028
- 世界の前立腺特異抗原（PSA）検査売上予測2017-2028
- 前立腺特異抗原（PSA）検査の地域別販売量
- 前立腺特異抗原（PSA）検査の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別前立腺特異抗原（PSA）検査販売量
- 主要メーカー別前立腺特異抗原（PSA）検査売上
- 主要メーカー別前立腺特異抗原（PSA）検査価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（ラジオイムノアッセイ、酵素イムノアッセイ）
- 前立腺特異抗原（PSA）検査の種類別販売量
- 前立腺特異抗原（PSA）検査の種類別売上
- 前立腺特異抗原（PSA）検査の種類別価格
・用途別市場規模（病院、クリニック、診断センター、研究所、その他）
- 前立腺特異抗原（PSA）検査の用途別販売量
- 前立腺特異抗原（PSA）検査の用途別売上
- 前立腺特異抗原（PSA）検査の用途別価格
・北米市場
- 北米の前立腺特異抗原（PSA）検査市場規模（種類別、用途別）
- 主要国別の前立腺特異抗原（PSA）検査市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの前立腺特異抗原（PSA）検査市場規模（種類別、用途別）
- 主要国別の前立腺特異抗原（PSA）検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の前立腺特異抗原（PSA）検査市場規模（種類別、用途別）
- 主要国別の前立腺特異抗原（PSA）検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の前立腺特異抗原（PSA）検査市場規模（種類別、用途別）
- 主要国別の前立腺特異抗原（PSA）検査市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの前立腺特異抗原（PSA）検査市場規模（種類別、用途別）
- 主要国別の前立腺特異抗原（PSA）検査市場規模（トルコ、サウジアラビア）
・企業情報
Cleveland Diagnostics、Abbott、Siemens Healthineers、DiaSorin、Roche Holding AG、Beckman Coulter、Mediwatch(LABORIE)、Boditech、Bristol Myers Squibb、GE Healthcare、Endocare、GlaxoSmith Kline、Anixa Biosciences、Ortho Clinical、Fujirebio、Merck
・産業チェーン及び販売チャネル分析
- 前立腺特異抗原（PSA）検査の産業チェーン分析
- 前立腺特異抗原（PSA）検査の原材料
- 前立腺特異抗原（PSA）検査の生産プロセス
- 前立腺特異抗原（PSA）検査の販売及びマーケティング
- 前立腺特異抗原（PSA）検査の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 前立腺特異抗原（PSA）検査の産業動向
- 前立腺特異抗原（PSA）検査のマーケットドライバー
- 前立腺特異抗原（PSA）検査の課題
- 前立腺特異抗原（PSA）検査の阻害要因
・主な調査結果

Market Analysis and Insights: Global Prostate Specific Antigen (PSA) Testing Market
The global Prostate Specific Antigen (PSA) Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Radioimmunoassay accounting for % of the Prostate Specific Antigen (PSA) Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Prostate Specific Antigen (PSA) Testing market size is valued at US$ million in 2021, while the North America and Europe Prostate Specific Antigen (PSA) Testing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Prostate Specific Antigen (PSA) Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Specific Antigen (PSA) Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Specific Antigen (PSA) Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Specific Antigen (PSA) Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Specific Antigen (PSA) Testing market.
Global Prostate Specific Antigen (PSA) Testing Scope and Market Size
Prostate Specific Antigen (PSA) Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Prostate Specific Antigen (PSA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Radioimmunoassay
Enzyme Immunoassay
Segment by Application
Hospitals
Clinics
Diagnostic Centers
Research Institute
Others
By Company
Cleveland Diagnostics
Abbott
Siemens Healthineers
DiaSorin
Roche Holding AG
Beckman Coulter
Mediwatch(LABORIE)
Boditech
Bristol Myers Squibb
GE Healthcare
Endocare
GlaxoSmith Kline
Anixa Biosciences
Ortho Clinical
Fujirebio
Merck
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Radioimmunoassay
1.2.3 Enzyme Immunoassay
1.3 Market by Application
1.3.1 Global Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.3.5 Research Institute
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Specific Antigen (PSA) Testing Market Perspective (2017-2028)
2.2 Prostate Specific Antigen (PSA) Testing Growth Trends by Region
2.2.1 Prostate Specific Antigen (PSA) Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Prostate Specific Antigen (PSA) Testing Historic Market Size by Region (2017-2022)
2.2.3 Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Region (2023-2028)
2.3 Prostate Specific Antigen (PSA) Testing Market Dynamics
2.3.1 Prostate Specific Antigen (PSA) Testing Industry Trends
2.3.2 Prostate Specific Antigen (PSA) Testing Market Drivers
2.3.3 Prostate Specific Antigen (PSA) Testing Market Challenges
2.3.4 Prostate Specific Antigen (PSA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Specific Antigen (PSA) Testing Players by Revenue
3.1.1 Global Top Prostate Specific Antigen (PSA) Testing Players by Revenue (2017-2022)
3.1.2 Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Players (2017-2022)
3.2 Global Prostate Specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Specific Antigen (PSA) Testing Revenue
3.4 Global Prostate Specific Antigen (PSA) Testing Market Concentration Ratio
3.4.1 Global Prostate Specific Antigen (PSA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Testing Revenue in 2021
3.5 Prostate Specific Antigen (PSA) Testing Key Players Head office and Area Served
3.6 Key Players Prostate Specific Antigen (PSA) Testing Product Solution and Service
3.7 Date of Enter into Prostate Specific Antigen (PSA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Specific Antigen (PSA) Testing Breakdown Data by Type
4.1 Global Prostate Specific Antigen (PSA) Testing Historic Market Size by Type (2017-2022)
4.2 Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Type (2023-2028)
5 Prostate Specific Antigen (PSA) Testing Breakdown Data by Application
5.1 Global Prostate Specific Antigen (PSA) Testing Historic Market Size by Application (2017-2022)
5.2 Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Prostate Specific Antigen (PSA) Testing Market Size (2017-2028)
6.2 North America Prostate Specific Antigen (PSA) Testing Market Size by Type
6.2.1 North America Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022)
6.2.2 North America Prostate Specific Antigen (PSA) Testing Market Size by Type (2023-2028)
6.2.3 North America Prostate Specific Antigen (PSA) Testing Market Share by Type (2017-2028)
6.3 North America Prostate Specific Antigen (PSA) Testing Market Size by Application
6.3.1 North America Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022)
6.3.2 North America Prostate Specific Antigen (PSA) Testing Market Size by Application (2023-2028)
6.3.3 North America Prostate Specific Antigen (PSA) Testing Market Share by Application (2017-2028)
6.4 North America Prostate Specific Antigen (PSA) Testing Market Size by Country
6.4.1 North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2017-2022)
6.4.2 North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Prostate Specific Antigen (PSA) Testing Market Size (2017-2028)
7.2 Europe Prostate Specific Antigen (PSA) Testing Market Size by Type
7.2.1 Europe Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022)
7.2.2 Europe Prostate Specific Antigen (PSA) Testing Market Size by Type (2023-2028)
7.2.3 Europe Prostate Specific Antigen (PSA) Testing Market Share by Type (2017-2028)
7.3 Europe Prostate Specific Antigen (PSA) Testing Market Size by Application
7.3.1 Europe Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022)
7.3.2 Europe Prostate Specific Antigen (PSA) Testing Market Size by Application (2023-2028)
7.3.3 Europe Prostate Specific Antigen (PSA) Testing Market Share by Application (2017-2028)
7.4 Europe Prostate Specific Antigen (PSA) Testing Market Size by Country
7.4.1 Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2017-2022)
7.4.2 Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size (2017-2028)
8.2 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Type
8.2.1 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Application
8.3.1 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region
8.4.1 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prostate Specific Antigen (PSA) Testing Market Size (2017-2028)
9.2 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Type
9.2.1 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022)
9.2.2 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Type (2023-2028)
9.2.3 Latin America Prostate Specific Antigen (PSA) Testing Market Share by Type (2017-2028)
9.3 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Application
9.3.1 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022)
9.3.2 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Application (2023-2028)
9.3.3 Latin America Prostate Specific Antigen (PSA) Testing Market Share by Application (2017-2028)
9.4 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country
9.4.1 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country (2017-2022)
9.4.2 Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size (2017-2028)
10.2 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Type
10.2.1 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Application
10.3.1 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Country
10.4.1 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Cleveland Diagnostics
11.1.1 Cleveland Diagnostics Company Details
11.1.2 Cleveland Diagnostics Business Overview
11.1.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Introduction
11.1.4 Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.1.5 Cleveland Diagnostics Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Prostate Specific Antigen (PSA) Testing Introduction
11.2.4 Abbott Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.2.5 Abbott Recent Developments
11.3 Siemens Healthineers
11.3.1 Siemens Healthineers Company Details
11.3.2 Siemens Healthineers Business Overview
11.3.3 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Introduction
11.3.4 Siemens Healthineers Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.3.5 Siemens Healthineers Recent Developments
11.4 DiaSorin
11.4.1 DiaSorin Company Details
11.4.2 DiaSorin Business Overview
11.4.3 DiaSorin Prostate Specific Antigen (PSA) Testing Introduction
11.4.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.4.5 DiaSorin Recent Developments
11.5 Roche Holding AG
11.5.1 Roche Holding AG Company Details
11.5.2 Roche Holding AG Business Overview
11.5.3 Roche Holding AG Prostate Specific Antigen (PSA) Testing Introduction
11.5.4 Roche Holding AG Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.5.5 Roche Holding AG Recent Developments
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Details
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Prostate Specific Antigen (PSA) Testing Introduction
11.6.4 Beckman Coulter Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.6.5 Beckman Coulter Recent Developments
11.7 Mediwatch(LABORIE)
11.7.1 Mediwatch(LABORIE) Company Details
11.7.2 Mediwatch(LABORIE) Business Overview
11.7.3 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Introduction
11.7.4 Mediwatch(LABORIE) Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.7.5 Mediwatch(LABORIE) Recent Developments
11.8 Boditech
11.8.1 Boditech Company Details
11.8.2 Boditech Business Overview
11.8.3 Boditech Prostate Specific Antigen (PSA) Testing Introduction
11.8.4 Boditech Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.8.5 Boditech Recent Developments
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Details
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Introduction
11.9.4 Bristol Myers Squibb Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.9.5 Bristol Myers Squibb Recent Developments
11.10 GE Healthcare
11.10.1 GE Healthcare Company Details
11.10.2 GE Healthcare Business Overview
11.10.3 GE Healthcare Prostate Specific Antigen (PSA) Testing Introduction
11.10.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.10.5 GE Healthcare Recent Developments
11.11 Endocare
11.11.1 Endocare Company Details
11.11.2 Endocare Business Overview
11.11.3 Endocare Prostate Specific Antigen (PSA) Testing Introduction
11.11.4 Endocare Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.11.5 Endocare Recent Developments
11.12 GlaxoSmith Kline
11.12.1 GlaxoSmith Kline Company Details
11.12.2 GlaxoSmith Kline Business Overview
11.12.3 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Introduction
11.12.4 GlaxoSmith Kline Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.12.5 GlaxoSmith Kline Recent Developments
11.13 Anixa Biosciences
11.13.1 Anixa Biosciences Company Details
11.13.2 Anixa Biosciences Business Overview
11.13.3 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Introduction
11.13.4 Anixa Biosciences Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.13.5 Anixa Biosciences Recent Developments
11.14 Ortho Clinical
11.14.1 Ortho Clinical Company Details
11.14.2 Ortho Clinical Business Overview
11.14.3 Ortho Clinical Prostate Specific Antigen (PSA) Testing Introduction
11.14.4 Ortho Clinical Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.14.5 Ortho Clinical Recent Developments
11.15 Fujirebio
11.15.1 Fujirebio Company Details
11.15.2 Fujirebio Business Overview
11.15.3 Fujirebio Prostate Specific Antigen (PSA) Testing Introduction
11.15.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.15.5 Fujirebio Recent Developments
11.16 Merck
11.16.1 Merck Company Details
11.16.2 Merck Business Overview
11.16.3 Merck Prostate Specific Antigen (PSA) Testing Introduction
11.16.4 Merck Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
11.16.5 Merck Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Radioimmunoassay
Table 3. Key Players of Enzyme Immunoassay
Table 4. Global Prostate Specific Antigen (PSA) Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Prostate Specific Antigen (PSA) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Prostate Specific Antigen (PSA) Testing Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Prostate Specific Antigen (PSA) Testing Market Share by Region (2017-2022)
Table 8. Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Prostate Specific Antigen (PSA) Testing Market Share by Region (2023-2028)
Table 10. Prostate Specific Antigen (PSA) Testing Market Trends
Table 11. Prostate Specific Antigen (PSA) Testing Market Drivers
Table 12. Prostate Specific Antigen (PSA) Testing Market Challenges
Table 13. Prostate Specific Antigen (PSA) Testing Market Restraints
Table 14. Global Prostate Specific Antigen (PSA) Testing Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Prostate Specific Antigen (PSA) Testing Revenue Share by Players (2017-2022)
Table 16. Global Top Prostate Specific Antigen (PSA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Testing as of 2021)
Table 17. Ranking of Global Top Prostate Specific Antigen (PSA) Testing Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Prostate Specific Antigen (PSA) Testing Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Prostate Specific Antigen (PSA) Testing Product Solution and Service
Table 21. Date of Enter into Prostate Specific Antigen (PSA) Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Type (2017-2022)
Table 25. Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Type (2023-2028)
Table 27. Global Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Prostate Specific Antigen (PSA) Testing Revenue Share by Application (2017-2022)
Table 29. Global Prostate Specific Antigen (PSA) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Prostate Specific Antigen (PSA) Testing Revenue Share by Application (2023-2028)
Table 31. North America Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Prostate Specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Prostate Specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Prostate Specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Prostate Specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Prostate Specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Prostate Specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Prostate Specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Prostate Specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size by Country (2023-2028) & (US$ Million)
Table 61. Cleveland Diagnostics Company Details
Table 62. Cleveland Diagnostics Business Overview
Table 63. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Product
Table 64. Cleveland Diagnostics Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 65. Cleveland Diagnostics Recent Developments
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Prostate Specific Antigen (PSA) Testing Product
Table 69. Abbott Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 70. Abbott Recent Developments
Table 71. Siemens Healthineers Company Details
Table 72. Siemens Healthineers Business Overview
Table 73. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Product
Table 74. Siemens Healthineers Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 75. Siemens Healthineers Recent Developments
Table 76. DiaSorin Company Details
Table 77. DiaSorin Business Overview
Table 78. DiaSorin Prostate Specific Antigen (PSA) Testing Product
Table 79. DiaSorin Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 80. DiaSorin Recent Developments
Table 81. Roche Holding AG Company Details
Table 82. Roche Holding AG Business Overview
Table 83. Roche Holding AG Prostate Specific Antigen (PSA) Testing Product
Table 84. Roche Holding AG Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 85. Roche Holding AG Recent Developments
Table 86. Beckman Coulter Company Details
Table 87. Beckman Coulter Business Overview
Table 88. Beckman Coulter Prostate Specific Antigen (PSA) Testing Product
Table 89. Beckman Coulter Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 90. Beckman Coulter Recent Developments
Table 91. Mediwatch(LABORIE) Company Details
Table 92. Mediwatch(LABORIE) Business Overview
Table 93. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Product
Table 94. Mediwatch(LABORIE) Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 95. Mediwatch(LABORIE) Recent Developments
Table 96. Boditech Company Details
Table 97. Boditech Business Overview
Table 98. Boditech Prostate Specific Antigen (PSA) Testing Product
Table 99. Boditech Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 100. Boditech Recent Developments
Table 101. Bristol Myers Squibb Company Details
Table 102. Bristol Myers Squibb Business Overview
Table 103. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Product
Table 104. Bristol Myers Squibb Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 105. Bristol Myers Squibb Recent Developments
Table 106. GE Healthcare Company Details
Table 107. GE Healthcare Business Overview
Table 108. GE Healthcare Prostate Specific Antigen (PSA) Testing Product
Table 109. GE Healthcare Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 110. GE Healthcare Recent Developments
Table 111. Endocare Company Details
Table 112. Endocare Business Overview
Table 113. Endocare Prostate Specific Antigen (PSA) Testing Product
Table 114. Endocare Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 115. Endocare Recent Developments
Table 116. GlaxoSmith Kline Company Details
Table 117. GlaxoSmith Kline Business Overview
Table 118. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Product
Table 119. GlaxoSmith Kline Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 120. GlaxoSmith Kline Recent Developments
Table 121. Anixa Biosciences Company Details
Table 122. Anixa Biosciences Business Overview
Table 123. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Product
Table 124. Anixa Biosciences Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 125. Anixa Biosciences Recent Developments
Table 126. Ortho Clinical Company Details
Table 127. Ortho Clinical Business Overview
Table 128. Ortho Clinical Prostate Specific Antigen (PSA) Testing Product
Table 129. Ortho Clinical Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 130. Ortho Clinical Recent Developments
Table 131. Fujirebio Company Details
Table 132. Fujirebio Business Overview
Table 133. Fujirebio Prostate Specific Antigen (PSA) Testing Product
Table 134. Fujirebio Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 135. Fujirebio Recent Developments
Table 136. Merck Company Details
Table 137. Merck Business Overview
Table 138. Merck Prostate Specific Antigen (PSA) Testing Product
Table 139. Merck Revenue in Prostate Specific Antigen (PSA) Testing Business (2017-2022) & (US$ Million)
Table 140. Merck Recent Developments
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Specific Antigen (PSA) Testing Market Share by Type: 2021 VS 2028
Figure 2. Radioimmunoassay Features
Figure 3. Enzyme Immunoassay Features
Figure 4. Global Prostate Specific Antigen (PSA) Testing Market Share by Application: 2021 VS 2028
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Research Institute Case Studies
Figure 9. Others Case Studies
Figure 10. Prostate Specific Antigen (PSA) Testing Report Years Considered
Figure 11. Global Prostate Specific Antigen (PSA) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Prostate Specific Antigen (PSA) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Prostate Specific Antigen (PSA) Testing Market Share by Region: 2021 VS 2028
Figure 14. Global Prostate Specific Antigen (PSA) Testing Market Share by Players in 2021
Figure 15. Global Top Prostate Specific Antigen (PSA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Specific Antigen (PSA) Testing as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Prostate Specific Antigen (PSA) Testing Revenue in 2021
Figure 17. North America Prostate Specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
Figure 19. North America Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
Figure 20. North America Prostate Specific Antigen (PSA) Testing Market Size Share by Country (2017-2028)
Figure 21. United States Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Prostate Specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
Figure 25. Europe Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
Figure 26. Europe Prostate Specific Antigen (PSA) Testing Market Size Share by Country (2017-2028)
Figure 27. Germany Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size Share by Region (2017-2028)
Figure 37. China Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Prostate Specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Prostate Specific Antigen (PSA) Testing Market Size Share by Country (2017-2028)
Figure 47. Mexico Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size Share by Country (2017-2028)
Figure 53. Turkey Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Prostate Specific Antigen (PSA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Cleveland Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 57. Abbott Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 58. Siemens Healthineers Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 59. DiaSorin Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 60. Roche Holding AG Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 61. Beckman Coulter Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 62. Mediwatch(LABORIE) Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 63. Boditech Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 64. Bristol Myers Squibb Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 65. GE Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 66. Endocare Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 67. GlaxoSmith Kline Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 68. Anixa Biosciences Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 69. Ortho Clinical Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 70. Fujirebio Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 71. Merck Revenue Growth Rate in Prostate Specific Antigen (PSA) Testing Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Global Human Leukocyte Antigen Testing Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E7965 2022年5月 109Pages
ヒト白血球抗原検査市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。...

世界の新型コロナウイルス感染症(COVID-19)抗原検査キット市場予測（～2028年）：PCR、Qpcr

Global COVID-19 Antigen Testing Kits Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E7733 2022年5月 129Pages
新型コロナウイルス感染症(COVID-19)抗原検査キット市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域...

前立腺がん診断ソリューションのグローバル市場インサイト・予測（～2028年）

Global Prostate Cancer Diagnostics Solution Market Insights, Forecast to 2028
QY2207E10028 2022年7月 113Pages
新型コロナウイルス感染症のパンデミックにより、世界の前立腺がん診断ソリューションの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に前立腺が...

特定学習障害治療のグローバル市場インサイト・予測（～2028年）

Global Specific Learning Disability Treatment Market Insights, Forecast to 2028
QY2207E09286 2022年7月 110Pages
新型コロナウイルス感染症のパンデミックにより、世界の特定学習障害治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に特定学習障害治療の世...

新型コロナウイルス感染症抗原検出試薬のグローバル市場インサイト・予測（～2028年）

Global COVID-19 Antigen Detection Reagent Market Insights, Forecast to 2028
QY2207C3861 2022年7月11日 114Pages
新型コロナウイルス感染症のパンデミックにより、世界の新型コロナウイルス感染症抗原検出試薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...

世界のヒト白血球抗原検査市場予測（～2028年）：分子アッセイ技術、非分子アッセイ技術 The Human Leukocyte Antigen Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
世界の新型コロナウイルス感染症(COVID-19)抗原検査キット市場予測（～2028年）：PCR、Qpcr The COVID-19 Antigen Testing Kits market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
前立腺がん診断ソリューションのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Prostate Cancer Diagnostics Solution Market The global Prostate Cancer Diagnostics Solution market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health cris…
特定学習障害治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Specific Learning Disability Treatment Market The global Specific Learning Disability Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health …
新型コロナウイルス感染症抗原検出試薬のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global COVID-19 Antigen Detection Reagent Market The global COVID-19 Antigen Detection Reagent market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, …